JP3251190B2 - 体液と接触することにより容積が高度に増加する薬学的圧縮錠剤 - Google Patents
体液と接触することにより容積が高度に増加する薬学的圧縮錠剤Info
- Publication number
- JP3251190B2 JP3251190B2 JP03491897A JP3491897A JP3251190B2 JP 3251190 B2 JP3251190 B2 JP 3251190B2 JP 03491897 A JP03491897 A JP 03491897A JP 3491897 A JP3491897 A JP 3491897A JP 3251190 B2 JP3251190 B2 JP 3251190B2
- Authority
- JP
- Japan
- Prior art keywords
- layer
- active ingredient
- tablet
- pharmaceutical
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96A000311 | 1996-02-19 | ||
| IT96MI000311A IT1282650B1 (it) | 1996-02-19 | 1996-02-19 | Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH09316005A JPH09316005A (ja) | 1997-12-09 |
| JP3251190B2 true JP3251190B2 (ja) | 2002-01-28 |
Family
ID=11373320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP03491897A Expired - Lifetime JP3251190B2 (ja) | 1996-02-19 | 1997-02-19 | 体液と接触することにより容積が高度に増加する薬学的圧縮錠剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5780057A (cg-RX-API-DMAC7.html) |
| EP (2) | EP0795324B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3251190B2 (cg-RX-API-DMAC7.html) |
| AT (2) | ATE264670T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU719170B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2197941C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69728710T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0795324T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2376199T3 (cg-RX-API-DMAC7.html) |
| IT (1) | IT1282650B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ314265A (cg-RX-API-DMAC7.html) |
| PT (1) | PT795324E (cg-RX-API-DMAC7.html) |
Families Citing this family (148)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534263A (en) | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
| CA2173818A1 (fr) * | 1996-04-10 | 1997-10-11 | Francois Chouinard | Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose |
| US5804165A (en) * | 1996-07-24 | 1998-09-08 | Arnold; Michael J. | Antiplaque oral composition |
| DE19640062B4 (de) * | 1996-09-28 | 2006-04-27 | Lts Lohmann Therapie-Systeme Ag | Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff |
| US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| IT1294760B1 (it) * | 1997-09-03 | 1999-04-12 | Jagotec Ag | Procedimento per la preparazione di compresse farmaceutiche in grado di cedere,secondo schemi predeterminabili, principi attivi poco |
| IN186245B (cg-RX-API-DMAC7.html) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
| GB9724186D0 (en) | 1997-11-14 | 1998-01-14 | British Tech Group | Low temperature coatings |
| DK0991415T3 (da) * | 1997-12-22 | 2003-06-16 | Schering Corp | Faste, oralt indgivelige dosisformer for ribavirin og fremgangsmåde til fremstilling af disse |
| CA2330581A1 (en) * | 1998-06-05 | 1999-12-09 | Warner-Lambert Company | Stabilization of compositions containing ace inhibitors using magnesium oxide |
| CA2340130A1 (en) * | 1998-09-25 | 2000-04-06 | Suggy S. Chrai | Liquid pharmaceutical for oral delivery |
| EP1137403B1 (en) | 1998-12-11 | 2009-03-11 | Nostrum Pharmaceuticals, Inc. | Sustained release tablet containing hydrocolloid and cellulose ether |
| US6797283B1 (en) | 1998-12-23 | 2004-09-28 | Alza Corporation | Gastric retention dosage form having multiple layers |
| US6635281B2 (en) | 1998-12-23 | 2003-10-21 | Alza Corporation | Gastric retaining oral liquid dosage form |
| US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
| US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
| MY121470A (en) * | 1999-05-03 | 2006-01-28 | Ranbaxy Lab Ltd | Stable solid pharmaceutical compositions containing enalapril maleate |
| US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
| FR2797185B1 (fr) * | 1999-08-06 | 2001-10-26 | Galenix Dev | Composition pharmaceutique flottante comprenant une phase active et une phase non active |
| US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
| JP4565456B2 (ja) * | 1999-11-02 | 2010-10-20 | 塩野義製薬株式会社 | 着色顆粒の色素定着法 |
| US6399101B1 (en) | 2000-03-30 | 2002-06-04 | Mova Pharmaceutical Corp. | Stable thyroid hormone preparations and method of making same |
| AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
| US8012504B2 (en) * | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
| US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
| US7838032B2 (en) * | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
| US7985420B2 (en) * | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
| US6372252B1 (en) | 2000-04-28 | 2002-04-16 | Adams Laboratories, Inc. | Guaifenesin sustained release formulation and tablets |
| US6881420B2 (en) | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
| JP2004501190A (ja) * | 2000-06-23 | 2004-01-15 | テバ ファーマシューティカル インダストリーズ リミティド | 治療薬の胃部保留および制御された放出のための急速膨張する組成物とその組成物を含む剤形 |
| US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
| WO2003097018A1 (en) * | 2002-02-04 | 2003-11-27 | Ranbaxy Laboratories Limited | Hydrodynamically balancing oral drug delivery system with biphasic release |
| US6932861B2 (en) | 2000-11-28 | 2005-08-23 | Fmc Corporation | Edible PGA coating composition |
| US6699315B2 (en) | 2000-11-28 | 2004-03-02 | Fmc Corporation | Edible PGA coating composition |
| AU2002221412B2 (en) * | 2000-12-05 | 2006-04-13 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
| KR100685945B1 (ko) | 2000-12-29 | 2007-02-23 | 엘지.필립스 엘시디 주식회사 | 액정표시장치 및 그 제조방법 |
| US8268333B2 (en) * | 2001-04-24 | 2012-09-18 | Lintec Corporation | Orally administered agent and an orally administered agent/supporting substrate complex |
| DE10120092B4 (de) * | 2001-04-25 | 2008-03-20 | Lts Lohmann Therapie-Systeme Ag | Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung |
| IL159813A0 (en) * | 2001-07-12 | 2004-06-20 | Teva Pharma | Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core |
| IL159812A0 (en) * | 2001-07-12 | 2004-06-20 | Teva Pharma | Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester in a controlled release core |
| US20030104052A1 (en) * | 2001-10-25 | 2003-06-05 | Bret Berner | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
| CA2409552A1 (en) * | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| US20030099699A1 (en) * | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
| AU2002340470A1 (en) | 2001-11-13 | 2003-05-26 | Teva Pharmaceutical Industries, Ltd. | L-dopa ethyl ester salts and uses thereof |
| WO2003042136A2 (en) * | 2001-11-13 | 2003-05-22 | Teva Pharmaceutical Industries, Ltd. | Process for the production of l-dopa ethyl ester |
| US6645526B2 (en) * | 2001-11-13 | 2003-11-11 | Mylan Pharmaceuticals, Inc. | Storage stable thyroxine active drug formulations and methods for their production |
| CA2470342C (en) * | 2001-12-21 | 2010-05-11 | Biopartners Gmbh | Ribavirin granulate for producing coated tablets |
| KR20030056474A (ko) * | 2001-12-28 | 2003-07-04 | 한국유나이티드제약 주식회사 | 카르비도파/레보도파 서방정의 조성물과 그의 제조방법 |
| US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| US7008979B2 (en) * | 2002-04-30 | 2006-03-07 | Hydromer, Inc. | Coating composition for multiple hydrophilic applications |
| US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| US20040005359A1 (en) * | 2002-06-27 | 2004-01-08 | Cheng Xiu Xiu | Controlled release oral dosage form |
| SI1551372T1 (en) | 2002-09-20 | 2018-08-31 | Alpharma Pharmaceuticals Llc | SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES |
| US8487002B2 (en) * | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
| TWI319713B (en) * | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
| WO2004041255A1 (en) * | 2002-10-31 | 2004-05-21 | Alza Corporation | Dosage form providing ascending release of liquid formulation |
| US8906413B2 (en) | 2003-05-12 | 2014-12-09 | Supernus Pharmaceuticals, Inc. | Drug formulations having reduced abuse potential |
| US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
| TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
| US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
| JP2005132803A (ja) * | 2003-10-31 | 2005-05-26 | Ono Pharmaceut Co Ltd | 胃内滞留固形剤 |
| EP1701725B1 (en) * | 2003-12-16 | 2013-07-31 | Relevare Aust. Pty Ltd | Compositions comprising flupirtine and an opioid for use in the treatment of neuropathic pain |
| WO2005079752A2 (en) * | 2004-02-11 | 2005-09-01 | Rubicon Research Private Limited | Controlled release pharmaceutical compositions with improved bioavailability |
| WO2005084703A1 (ja) * | 2004-03-09 | 2005-09-15 | Nrl Pharma, Inc. | 徐放性の口腔用組成物 |
| FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
| AU2005295482B2 (en) * | 2004-10-15 | 2011-03-31 | Supernus Pharmaceuticals Inc. | Less abusable pharmaceutical preparations |
| JP2008520726A (ja) * | 2004-11-19 | 2008-06-19 | スミスクライン・ビーチャム・コーポレイション | 医薬製品 |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| US20060159753A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Matrix type sustained-release preparation containing basic drug or salt thereof |
| US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| CA2592605C (en) * | 2004-12-27 | 2010-12-07 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
| EP1901720A2 (en) * | 2005-06-23 | 2008-03-26 | Spherics, Inc. | Improved dosage forms for movement disorder treatment |
| RS20070512A (sr) * | 2005-06-29 | 2009-01-22 | Panacea Biotec Ltd., | Farmaceutske kompozicije sa zadržanim otpuštanjem i postupci za njihovo dobijanje |
| SI1931346T1 (sl) * | 2005-09-09 | 2012-10-30 | Angelini Labopharm Llc | Trazodonski sestavek za dajanje enkrat dnevno |
| ES2620293T3 (es) * | 2005-09-09 | 2017-06-28 | Paladin Labs Inc. | Composición de liberación sostenida de fármacos |
| NL2000281C2 (nl) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
| US8187633B2 (en) | 2005-11-03 | 2012-05-29 | Sun Pharma Advanced Research Company Limited | Controlled release coated tablets having prolonged gastric retention |
| WO2007056570A2 (en) * | 2005-11-07 | 2007-05-18 | Teva Pharmaceutical Industries Ltd. | Levodopa compositions |
| US7674396B2 (en) * | 2005-11-08 | 2010-03-09 | Plensat Llc | Method and system for treatment of eating disorders |
| US8691272B2 (en) | 2005-12-30 | 2014-04-08 | Intelgenx Corp. | Multilayer tablet |
| KR100752417B1 (ko) * | 2006-02-14 | 2007-08-28 | 대원제약주식회사 | 안정성이 증진된, 마진돌을 포함하는 약제학적 조성물 |
| US9011930B2 (en) * | 2006-05-01 | 2015-04-21 | Zycal Bioceuticals Healthcare Company, Inc. | Nutritional supplement and use thereof |
| WO2007128056A1 (en) * | 2006-05-03 | 2007-11-15 | Cnsbio Pty Ltd | Methods and composition for treatment of inflammatory pain |
| US20100297226A1 (en) * | 2006-06-01 | 2010-11-25 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
| SI2484346T1 (sl) | 2006-06-19 | 2017-05-31 | Alpharma Pharmaceuticals Llc | Farmacevtski sestavki |
| US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
| EP2063872B2 (en) | 2006-08-30 | 2019-12-04 | Jagotec AG | Controlled release oral dosage formulations comprising a core and one or more barrier layers |
| US20080181947A1 (en) * | 2006-09-26 | 2008-07-31 | Astellas Pharma Inc. | Controlled release dosage form of tacrolimus |
| WO2008039193A2 (en) * | 2006-09-26 | 2008-04-03 | Plensat, Llc | Method and system for treatment of eating disorders |
| WO2008039186A2 (en) * | 2006-09-26 | 2008-04-03 | Plensat, Llc | Method and system for treatment of eating disorders |
| EP1935411A1 (en) | 2006-12-15 | 2008-06-25 | Campina Nederland Holding B.V. | Slow release excipient and its use |
| CA2673511A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| WO2008084698A1 (ja) | 2006-12-28 | 2008-07-17 | Astellas Pharma Inc. | タクロリムス徐放性医薬組成物 |
| AT505225A1 (de) * | 2007-04-26 | 2008-11-15 | Sanochemia Pharmazeutika Ag | 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen |
| US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
| CN102123702A (zh) * | 2008-06-16 | 2011-07-13 | 阿庇安实验室有限责任公司 | 制备恒定(零级)释放活性剂的释放体系的组合物和方法 |
| ES2740360T3 (es) | 2008-08-15 | 2020-02-05 | Assertio Therapeutics Inc | Composiciones farmacéuticas de retención gástrica para el tratamiento y la prevención de trastornos del SNC |
| BRPI0914080A2 (pt) | 2008-10-08 | 2015-10-27 | Bioplus Life Sciences Pvt Ltda | "sistema de liberação de dosagem controlada, método de administração e processo de preparação do mesmo" |
| EP2358358A2 (en) * | 2008-10-23 | 2011-08-24 | Appian Labs, Llc | Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates |
| US20100233259A1 (en) * | 2008-12-12 | 2010-09-16 | Pascal Grenier | Dosage form of ropinirole |
| EP2210585A1 (en) | 2009-01-16 | 2010-07-28 | Exelgyn | SPRM pharmaceutical compositions methods of treatment using them |
| US20100249423A1 (en) * | 2009-03-09 | 2010-09-30 | Sanochemia Pharmazeutika Ag | Tolperisone controlled release tablet |
| US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
| US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
| US10485770B2 (en) | 2009-12-21 | 2019-11-26 | Aptapharma, Inc. | Functionally-coated multilayer tablets |
| ES2665467T3 (es) | 2010-03-29 | 2018-04-25 | Astellas Pharma Inc. | Composición farmacéutica de liberación modificada |
| JP5459670B2 (ja) * | 2010-05-07 | 2014-04-02 | 塩野義製薬株式会社 | 着色顆粒の色素定着化剤 |
| AU2012345659B2 (en) * | 2011-12-02 | 2017-09-28 | Synchroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| EP2806861A1 (en) | 2012-01-23 | 2014-12-03 | Ranbaxy Laboratories Limited | In-situ multilayered tablet technology |
| WO2014197744A1 (en) | 2013-06-05 | 2014-12-11 | Synchroneuron, Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
| CN105658211A (zh) | 2013-10-07 | 2016-06-08 | 怡百克制药公司 | 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途 |
| US10485758B2 (en) | 2014-06-02 | 2019-11-26 | Clexio Biosciences Ltd. | Expandable gastroretentive dosage form |
| GB201506755D0 (en) | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
| US9617230B2 (en) | 2014-12-22 | 2017-04-11 | Farmington Pharma Development | Creatine prodrugs, compositions and methods of use thereof |
| EP3247384B1 (en) | 2015-01-14 | 2023-10-04 | The Regents of the University of Colorado, a body corporate | In vitro method of diagnosis of type 1 diabetes with insulin mimotopes |
| WO2016128972A1 (en) * | 2015-02-09 | 2016-08-18 | Entera Bio Ltd. | Formulations for oral administration of active agents with controlled absorption profile |
| US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| EP3364955B1 (en) | 2015-10-09 | 2022-04-20 | RB Health (US) LLC | Pharmaceutical formulation |
| US9675585B1 (en) | 2016-03-24 | 2017-06-13 | Ezra Pharma | Extended release pharmaceutical formulations |
| US9687475B1 (en) | 2016-03-24 | 2017-06-27 | Ezra Pharma Llc | Extended release pharmaceutical formulations with controlled impurity levels |
| CA3018727C (en) | 2016-03-24 | 2024-03-26 | The Regents Of The University Of Colorado, A Body Corporate | Methods of treating autoimmune disease |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| MX2019001850A (es) | 2016-08-17 | 2019-05-15 | Entera Bio Ltd | Formulaciones para administracion oral de principios activos. |
| ES2966736T3 (es) | 2016-12-02 | 2024-04-24 | Clexio Biosciences Ltd | Sistema de residencia gástrica |
| KR102039345B1 (ko) * | 2017-02-01 | 2019-11-01 | 지엘팜텍주식회사 | 프레가발린 함유 고팽윤성 서방성 삼중정제 |
| US11332438B2 (en) | 2017-12-01 | 2022-05-17 | Ultragenyx Pharmaceutical Inc. | Creatine prodrugs, compositions and methods of use thereof |
| WO2019111132A1 (en) | 2017-12-04 | 2019-06-13 | Clexio Biosciences Ltd. | Long acting gastric residence system |
| US11337920B2 (en) | 2017-12-18 | 2022-05-24 | Tris Pharma, Inc. | Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release |
| AU2018388577B2 (en) | 2017-12-18 | 2024-06-06 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release |
| US12514818B2 (en) | 2017-12-18 | 2026-01-06 | Tris Pharma, Inc. | Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system |
| US11666546B2 (en) | 2017-12-18 | 2023-06-06 | Tris Pharma, Inc | GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system |
| US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
| US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
| CA3097594A1 (en) * | 2018-05-15 | 2019-11-21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Pharmaceutical composition comprising small molecule egfr inhibitor and preparation method therefor |
| CN110214860A (zh) * | 2019-07-10 | 2019-09-10 | 聂刘明 | 一种宠物饲料及其制备工艺 |
| US12194150B2 (en) | 2020-12-22 | 2025-01-14 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
| US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
| US12409163B2 (en) | 2021-07-30 | 2025-09-09 | Evecxia Therapeutics, Inc. | Method of enhancing 5-hydroxytryptophan (5-HTP) exposure |
| AU2022320730A1 (en) * | 2021-07-30 | 2024-03-14 | Evecxia Therapeutics, Inc. | 5-hydroxytryptophan gastroretentive dosage forms |
| US11779567B2 (en) | 2021-10-14 | 2023-10-10 | Evecxia Therapeutics, Inc. | Method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes |
| WO2023214018A1 (en) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Gastro-retentive swellable sustained release composition |
| CN121038779A (zh) | 2023-02-03 | 2025-11-28 | 特瑞斯制药公司 | 每晚一次的低钠羟丁酸盐组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4839171A (en) * | 1984-11-30 | 1989-06-13 | Techmix, Inc. | Composition for treating impaired lactation |
| IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
| JPH0747534B2 (ja) * | 1986-06-02 | 1995-05-24 | ロ−ラ−ジヤパン株式会社 | 錠 剤 |
| US4869908A (en) * | 1987-01-09 | 1989-09-26 | K.V. Pharmaceutical Co. | Fibre formulations |
| US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
| DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
| IT1237904B (it) * | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
| IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
| IT1256393B (it) * | 1992-11-17 | 1995-12-04 | Inverni Della Beffa Spa | Forme matriciali multistrato per il rilascio controllato di principi attivi |
| IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
| US5464633A (en) * | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
-
1996
- 1996-02-19 IT IT96MI000311A patent/IT1282650B1/it active IP Right Grant
-
1997
- 1997-02-14 US US08/799,313 patent/US5780057A/en not_active Expired - Lifetime
- 1997-02-18 NZ NZ314265A patent/NZ314265A/en not_active IP Right Cessation
- 1997-02-18 EP EP97102567A patent/EP0795324B1/en not_active Expired - Lifetime
- 1997-02-18 AU AU14776/97A patent/AU719170B2/en not_active Expired
- 1997-02-18 ES ES03078109T patent/ES2376199T3/es not_active Expired - Lifetime
- 1997-02-18 AT AT97102567T patent/ATE264670T1/de active
- 1997-02-18 ES ES97102567T patent/ES2219709T3/es not_active Expired - Lifetime
- 1997-02-18 EP EP03078109A patent/EP1382331B1/en not_active Expired - Lifetime
- 1997-02-18 DE DE69728710T patent/DE69728710T2/de not_active Expired - Lifetime
- 1997-02-18 DK DK97102567T patent/DK0795324T3/da active
- 1997-02-18 AT AT03078109T patent/ATE530173T1/de not_active IP Right Cessation
- 1997-02-18 PT PT97102567T patent/PT795324E/pt unknown
- 1997-02-19 JP JP03491897A patent/JP3251190B2/ja not_active Expired - Lifetime
- 1997-02-19 CA CA002197941A patent/CA2197941C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU719170B2 (en) | 2000-05-04 |
| ES2376199T3 (es) | 2012-03-09 |
| DE69728710D1 (de) | 2004-05-27 |
| ATE264670T1 (de) | 2004-05-15 |
| AU1477697A (en) | 1997-08-28 |
| CA2197941C (en) | 2001-12-04 |
| ES2376199T8 (es) | 2012-04-04 |
| US5780057A (en) | 1998-07-14 |
| EP0795324A2 (en) | 1997-09-17 |
| EP0795324A3 (en) | 1998-11-04 |
| JPH09316005A (ja) | 1997-12-09 |
| EP1382331A1 (en) | 2004-01-21 |
| ES2219709T3 (es) | 2004-12-01 |
| NZ314265A (en) | 1997-07-27 |
| ITMI960311A0 (cg-RX-API-DMAC7.html) | 1996-02-19 |
| PT795324E (pt) | 2004-09-30 |
| CA2197941A1 (en) | 1997-08-20 |
| IT1282650B1 (it) | 1998-03-31 |
| EP0795324B1 (en) | 2004-04-21 |
| ITMI960311A1 (it) | 1997-08-19 |
| EP1382331B1 (en) | 2011-10-26 |
| DE69728710T2 (de) | 2005-04-07 |
| DK0795324T3 (da) | 2004-08-16 |
| ATE530173T1 (de) | 2011-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1382331B1 (en) | A pharmaceutical tablet characterized by showing a high volume increase when coming into contact with biological fluids | |
| EP1681051B1 (en) | Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers | |
| RU2183459C2 (ru) | Таблетка с регулируемым высвобождением алфузозина гидрохлорида | |
| ES2295062T3 (es) | Formulacion granulada de liberacion sostenida. | |
| US20040052844A1 (en) | Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins | |
| US20160038411A1 (en) | Pulsatile gastric retentive dosage forms | |
| US20040234608A1 (en) | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | |
| JP2004501190A (ja) | 治療薬の胃部保留および制御された放出のための急速膨張する組成物とその組成物を含む剤形 | |
| JP2002533380A (ja) | 多孔性粒子を含む剤形 | |
| JPH11501948A (ja) | プロトンポンプ阻害剤およびnsaidからなる経口用医薬剤形 | |
| TW200418524A (en) | Methods and dosage forms for controlled delivery of paliperidone | |
| JPH0624959A (ja) | 胃内浮遊型薬物徐放性固形製剤 | |
| CN113476421B (zh) | 一种非布司他的控释组合物及其制备方法 | |
| KR101277021B1 (ko) | 위체류 약물 전달시스템을 이용한 경구용 방출제어형 레바미피드-함유 이층정 제제 및 그 제조방법 | |
| WO2004037228A1 (en) | Sustained release compositions containing alfuzosin | |
| JP5826456B2 (ja) | コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物 | |
| WO1997025028A1 (en) | Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads | |
| JP2006507298A (ja) | 経口持続放出型錠剤、ならびにその製造法および使用法 | |
| CN1564691A (zh) | 一种止痉挛剂的间隔药物释出系统 | |
| US20080206338A1 (en) | Controlled release formulations of an alpha-adrenergic receptor antagonist | |
| HK1053602B (en) | Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071116 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081116 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091116 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101116 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111116 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121116 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121116 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131116 Year of fee payment: 12 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |